SCHEMBL26447969

SCHEMBL26447969

CN(C)c1nc2ccc(-c3nc(Nc4ccc(N5CCNCC5)cn4)ncc3F)cc2s1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK2 Q92630 4/20 0.83
▸ CDK6 Q00534 16/20 0.71
▸ PIM1 P11309 5/20 0.71
▸ CCND1 P24385 10/20 0.64
▸ CDK4 P11802 10/20 0.64
▸ CDK2 P24941 8/20 0.64
▸ CCNA2 P20248 8/20 0.64
▸ CCNT1 O60563 6/20 0.64
▸ CDK9 P50750 6/20 0.64
▸ CDK7 P50613 4/20 0.64
▸ CCNH P51946 4/20 0.64
▸ MNAT1 P51948 4/20 0.64
▸ PIM3 Q86V86 1/20 0.64
▸ CDK1 P06493 4/20 0.63
▸ CYP2C9 P11712 1/20 0.63
▸ CCNB1 P14635 1/20 0.63
▸ CCNE1 P24864 1/20 0.63
▸ CYP2C19 P33261 1/20 0.63
▸ CDK5 Q00535 1/20 0.63
▸ KCNH2 Q12809 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL26679980 0.99 DYRK2 (0.84) DYRK2CDK6PIM1CCND1CDK4
Hydrochloric Acid SCHEMBL30679276 0.99 DYRK2 (0.84) DYRK2CDK6PIM1CCND1CDK4
SCHEMBL26447995 0.91 DYRK2 (0.98) DYRK2CDK6PIM1CCND1CDK4
Hydrochloric Acid SCHEMBL26679994 0.91 DYRK2 (1.00) DYRK2CDK6PIM1CCND1CDK4
SCHEMBL26447954 0.87 DYRK2 (0.80) DYRK2CDK6CCND1CDK4CCNA2
Hydrochloric Acid SCHEMBL26679999 0.86 DYRK2 (0.81) DYRK2CDK6CCND1
Hydrochloric Acid SCHEMBL30679271 0.86 DYRK2 (0.81) DYRK2CDK6CCND1
SCHEMBL26447960 0.86 DYRK2 (0.86) DYRK2CDK6PIM1CCND1
Hydrochloric Acid SCHEMBL32677349 0.85 DYRK2 (0.85) DYRK2CDK6PIM1CCND1
Hydrochloric Acid SCHEMBL26679986 0.85 DYRK2 (0.85) DYRK2CDK6PIM1CCND1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282864-A1 CDK6/DYRK2 DUAL-TARGET INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. (CN) 2023-11-29 — — EP disclosed
US-20230303553-A1 CDK6/DYRK2 DUAL-TARGET INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF JIANGSU TASLY DIYI PHARMACEUTICAL CO., LTD. (CN) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303553-A1 CDK6/DYRK2 DUAL-TARGET INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF CDK6, DYRK2, CDK16 DYRK2 2/4885CDK6 1/4885PIM1 393/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback